NetDr.com Since 1998 source for: Viagra [ sildenafil citrate ], Propecia/Proscar [ finasteride ], Cialis and Levitra.

Cart | Login

Medications

Hair Loss

Weight Loss

Xenical

Cosmetic

Latisse

Sexual Health

Skin Care

OHSU cancer institute researcher discovers new predictor of prostate cancer recurrence 2008-02-14

By Christine Decker

An Oregon Health & Science University Cancer Institute researcher has found a biomarker that may help improve the ability to predict if a man’s prostate cancer is going to come back after surgical removal.

PSA testing can predict advanced prostate cancer 2008-02-14

By Jeanne D'Agostino

A single prostate specific antigen (PSA) test taken before the age of 50 can be used to predict advanced prostate cancer in men up to 25 years in advance of a diagnosis, according to a new study published by researchers at Memorial Sloan-Kettering Canc

Finding May Solve Riddle of Fatigue in Muscles 2008-02-12

By Gina Kolata

One of the great unanswered questions in physiology is why muscles get tired. The experience is universal, common to creatures that have muscles, but the answer has been elusive until now.

They've got the beat 2008-02-11

By Bill Becher

Heart rate monitors can tell you when to push harder and when to back off -- but only when used properly.

Men who are continually active at work may have a decreased risk of prostate cancer 2008-02-11

By Kim Irwin

Men with jobs that require them to be physically active may be getting benefits beyond salary and health insurance - they may be at a decreased risk of developing prostate cancer, according to a study at UCLA’s Jonsson Cancer Center.

Merck to Settle U.S. Claims for $671 Million 2008-02-08

By Associated Press

Merck to Settle U.S. Claims for $671 Million

Drug Ads Raise Questions for Heart Pioneer 2008-02-07

By Stephanie Saul

Drug Ads Raise Questions for Heart Pioneer

Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer 2008-02-06

By Zoila Brown

Henry Ford Hospital is embarking on an expanded major clinical trial involving the use of gene therapy in combination with radiation therapy, to determine if the combined treatment is more effective than radiation therapy alone for patients with interm

Online tool supports more dialogue on prostate cancer risk 2008-02-04

By Natalie Chung-Sayers

Validated nomogram tool can identify normal PSA level patients at risk for aggressive prostate cancer and has been shown to perform better than conventional screening

New, noninvasive prostate cancer test beats PSA in detecting prostate cancer 2008-02-01

By Staci Vernick Goldberg

An experimental biomarker test developed by researchers at the University of Michigan more accurately detects prostate cancer than any other screening method currently in use, according to a study published in the February 1 issue of Cancer Research, a

Prostate cancer: Watchful wait or vaccinate? 2008-02-01

By Staci Vernick Goldberg

Researchers at the University of Southern California have developed a prostate cancer vaccine that prevented the development of cancer in 90 percent of young mice genetically predestined to develop the disease.

Great Drug, but Does It Prolong Life? 2008-01-29

By Tara Pope

Statins are among the most prescribed drugs in the world, and there is no doubt that they work as advertised -- that they lower not only cholesterol but also the risk for heart attack.

Nanomedicine research for prostate cancer supported by $5 million gift 2008-01-29

By Andrew Klein

The Prostate Cancer Foundation, largely through the generosity of David H. Koch, has given $5 million to four institutions, including Weill Cornell Medical College, to support novel research in prostate cancer. The gift is one of the largest-ever indiv

Sex hormones unrelated to prostate cancer risk 2008-01-29

By Liz Savage

Sex hormones circulating in the blood do not appear to be associated with prostate cancer risk, according to data from 18 prior studies. The analysis will be published online January 29 in the Journal of the National Cancer Institute.

Researchers confirm genetic alteration that triggers prostate cancer in mice and man 2008-01-28

By Kristen Woodward

A team of researchers led by Valeri Vasioukhin, Ph.D., and Peter Nelson, M.D., both investigators in the Human Biology Division at Fred Hutchinson Cancer Research Center, has confirmed that a molecular change found in human prostate cancers triggers th

What's Cholesterol Got to Do With It? 2008-01-27

By Gary Taube

The idea that cholesterol plays a key role in heart disease is so tightly woven into modern medical thinking that it is no longer considered open to question. This is the message that emerged all too clearly from the recent news that the drug Vytorin h

Heart Group Backs Drug Made by Ally 2008-01-24

By Stephanie Saul

Heart Group Backs Drug Made by Ally

What That Cholesterol Trial Showed, and What It Didn't 2008-01-22

By Tara Pope

The cholesterol drug Vytorin became known for its commercials showing people who look oddly similar to foods like tacos and banana cream pie. But now Vytorin is getting attention that is anything but funny.

Pros, cons of drug proven to prevent prostate cancer should be considered, researchers recommend 2008-01-21

By Erin Prather Stafford

Findings by UT Southwestern Medical Center researchers encourage men to weigh both the potential benefits and side effects of the drug finasteride before taking it to prevent prostate cancer.

Cholesterol As a Danger Has Skeptics 2008-01-17

By Alex Berenson

For decades, the theory that lowering cholesterol is always beneficial has been a core principle of cardiology. It has been accepted by doctors and used by drug makers to win quick approval for new medicines to reduce cholesterol.

READ MORE

<<... <... 610 611 612 613 614 615 616 617 618 619 ...> ...>>

Patent Pending: 60/481641

Email Us

About Us Privacy Policy Doctor Login